Ameditech Inc recalls Alere iScreen Dx Urine Drug Screen Card, 20 Drug Detection, Kit Contents include 26 individually pouched devices and 1…
- Recall date
- June 26, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-3084-2017
- FDA classification
- Class III
- Brand / firm
- Ameditech Inc
- Sold / distributed
- Nationwide Distribution to AZ, IL, IN, KY, NV, PA, TN, and TX
Why it was recalled
The kit box label incorrectly identifies PCP (instead of TCA) as one of the 10 drug analytes included in the kit. The pouch label, product insert, and the device itself are labeled correctly.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Alere iScreen Dx Urine Drug Screen Card, 20 Drug Detection, Kit Contents include 26 individually pouched devices and 1 IFU insert. The Alere iScreen Dx Drug Screen Card is a rapid urine screening test that can be performed without the use of an instrument. The test utilizes monoclonal antibodies to selectively detect elevated levels of specific drugs in urine
Get recall alerts
Free email alert whenever Ameditech Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Ameditech Inc